EUR 23.6
(1.72%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 13.05 Million EUR | 0.48% |
2022 | 12.99 Million EUR | 220.76% |
2021 | 4.05 Million EUR | -46.82% |
2020 | 7.61 Million EUR | -59.02% |
2019 | 18.58 Million EUR | 31.93% |
2018 | 14.08 Million EUR | -0.02% |
2017 | 14.09 Million EUR | 0.02% |
2016 | 14.08 Million EUR | 40.17% |
2015 | 10.04 Million EUR | -73.35% |
2014 | 37.71 Million EUR | 18.47% |
2013 | 31.83 Million EUR | -4.3% |
2012 | 33.26 Million EUR | 86.43% |
2011 | 17.84 Million EUR | 227.97% |
2010 | 5.44 Million EUR | 2052.82% |
2009 | 252.7 Thousand EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 8.33 Million EUR | 0.0% |
2023 Q4 | 13.05 Million EUR | 0.0% |
2023 Q2 | 13.04 Million EUR | 0.0% |
2023 FY | 13.05 Million EUR | 0.48% |
2022 Q2 | 4.06 Million EUR | 0.0% |
2022 Q4 | 12.99 Million EUR | 0.0% |
2022 FY | 12.99 Million EUR | 220.76% |
2021 Q4 | 4.05 Million EUR | 0.0% |
2021 Q2 | 4.4 Million EUR | 0.0% |
2021 FY | 4.05 Million EUR | -46.82% |
2020 Q2 | 11.98 Million EUR | 0.0% |
2020 FY | 7.61 Million EUR | -59.02% |
2020 Q4 | 7.61 Million EUR | 0.0% |
2019 FY | 18.58 Million EUR | 31.93% |
2019 Q4 | 18.58 Million EUR | 0.0% |
2019 Q2 | 22.63 Million EUR | 0.0% |
2018 Q4 | 14 Million EUR | 0.0% |
2018 FY | 14.08 Million EUR | -0.02% |
2018 Q2 | 14 Million EUR | 0.0% |
2017 Q4 | 14 Million EUR | 0.0% |
2017 Q2 | 14 Million EUR | 0.0% |
2017 FY | 14.09 Million EUR | 0.02% |
2016 FY | 14.08 Million EUR | 40.17% |
2016 Q2 | 7.01 Million EUR | 0.0% |
2016 Q4 | 14 Million EUR | 0.0% |
2015 Q4 | 10.04 Million EUR | 0.0% |
2015 FY | 10.04 Million EUR | -73.35% |
2015 Q2 | 51.92 Million EUR | 0.0% |
2014 Q4 | 37.71 Million EUR | 0.0% |
2014 FY | 37.71 Million EUR | 18.47% |
2014 Q2 | 37.43 Million EUR | 0.0% |
2013 Q4 | 31.83 Million EUR | 0.0% |
2013 FY | 31.83 Million EUR | -4.3% |
2013 Q2 | 35.52 Million EUR | 0.0% |
2012 Q3 | - EUR | -100.0% |
2012 Q1 | - EUR | -100.0% |
2012 FY | 33.26 Million EUR | 86.43% |
2012 Q2 | 32.26 Million EUR | 0.0% |
2012 Q4 | 33.26 Million EUR | 0.0% |
2011 FY | 17.84 Million EUR | 227.97% |
2011 Q4 | 17.84 Million EUR | 0.0% |
2011 Q2 | 10.1 Million EUR | 0.0% |
2010 Q4 | 5.44 Million EUR | 0.0% |
2010 FY | 5.44 Million EUR | 2052.82% |
2009 FY | 252.7 Thousand EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Apontis Pharma AG | 6 Million EUR | -117.574% |
Dermapharm Holding SE | 1.08 Billion EUR | 98.792% |
Evotec SE | 626.19 Million EUR | 97.915% |
MERCK Kommanditgesellschaft auf Aktien | 9.94 Billion EUR | 99.869% |
PharmaSGP Holding SE | 73.97 Million EUR | 82.353% |
SynBiotic SE | 3.68 Million EUR | -254.716% |